Viagra: is it an effective treatment for stillbirth (STRIDER)
-
Authors list
Dr Elizabeth Cottrell, Dr Sarah Finn-Sell, Dr Mark Dilworth, Dr Sue Greenwood, Dr Mark Wareing, Professor Philip Baker, Professor Sandy Davidge, Professor Colin Sibley
-
Research centre
This study is now complete.
Several drugs already in use have potential as treatments for pre-eclampsia and fetal growth restriction, by improving blood flow in the placenta. This means that it is easier for the baby to get the food and oxygen it needs in the womb.
We studied some of these drugs in mice, to find out how well they work and to make sure they are safe for use in pregnancy. We found that sildenafil (better known by its brand name Viagra), improves the function of blood vessels taken from human placentas. We have also shown in a small study in Canada that Viagra improves the growth of babies with FGR.
Based on the results of this small study, the Medical Research Council has provided £3m to fund a multi-centre clinical trial of Viagra for the treatment of FGR. The Manchester Placenta Clinic is playing a major role in this study, and we hope that it will pave the way for effective treatments for fetal growth restriction.
The UK study finished recruitment ahead of schedule this year, which is almost unprecedented in this sort of study. This was mainly due to our Placenta Clinic, which recruited 41 women out of a total of 126 nationwide.
Get our research updates
Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. We can keep you updated on our research news. If you're interested in being kept updated about our research and news from Tommy's, click here.
This study takes place in a Tommy's centre and is funded by the Medical Research Council
More research projects
-
Research into stillbirth
Research into stillbirthWhen a baby dies after 24 weeks of gestation, it is called a stillbirth. Nearly 3000 families a year get the devastating news that their baby is not alive. Our research is helping to change this. -
The AFFIRM trial for prevention of stillbirth
The AFFIRM trial for prevention of stillbirthResearchers supported by Tommy’s are looking at whether a package of care and resources for pregnant women can help stop stillbirths. -
Assessing how healthy babies are when they start moving less than normal (FEMINA2)
Assessing how healthy babies are when they start moving less than normal (FEMINA2)Reduced fetal movements are a common reason for women to go to hospital in the last 12 weeks of pregnancy. There is currently no way to know which women will have a normal pregnancy and which have problems. -
Assessing how healthy babies are when they start moving less than normal (FEMINA3)
Assessing how healthy babies are when they start moving less than normal (FEMINA3)Reduced fetal movements are a common reason for women to go to hospital in the last 12 weeks of pregnancy. But there is still no way to accurately tell which women will have a normal pregnancy, and which will have problems. -
Bile acid levels increases the risk of poor outcomes of pregnancies with intrahepatic cholestasis of pregnancy (ICP)
Bile acid levels increases the risk of poor outcomes of pregnancies with intrahepatic cholestasis of pregnancy (ICP)Researchers have looked at information from 5,500 women with ICP, finding that the babies of women with high bile acid levels are most at risk of stillbirth. -
Homing peptides: targeting drugs to the placenta
Homing peptides: targeting drugs to the placentaDrugs which could help prevent pregnancy complications can’t reach the placenta effectively. Tommy’s researchers are making use of ‘homing peptides’ to deliver drugs directly to the placenta. This work could help to prevent pregnancy complications and stillbirth. -
Can low levels of taurine make stillbirth more likely?
Can low levels of taurine make stillbirth more likely?Tommy’s researchers are looking at how the lack of an important nutrient might harm the placenta during pregnancy, putting women at a higher risk of stillbirth. -
Can steroid injections improve blood flow to babies at risk of stillbirth?
Can steroid injections improve blood flow to babies at risk of stillbirth?Finding out whether steroids can improve the blood flow through the placenta -
Comparing 2D and 3D MRI to study the placenta
Comparing 2D and 3D MRI to study the placentaOur scientists are developing new ways to use MRI scans to study the placenta, so that we can understand how it works and how its structure and function change during pregnancy. This will help us prevent complications like stillbirth and miscarriage. -
Could beetroot juice be used to treat fetal growth restriction?
Could beetroot juice be used to treat fetal growth restriction?Fetal growth restriction is often caused by reduced blood flow across the placenta. Researchers funded by Tommy’s have found that beetroot juice, which is rich in a nutrient called nitrate, could potentially reduce blood pressure and improve blood flow to placenta. -
Improving support in a pregnancy after stillbirth or neonatal death (the IMPS study)
Improving support in a pregnancy after stillbirth or neonatal death (the IMPS study)Our study aims to find out more about people's experiences of care in pregnancy after a loss and what extra support they would find helpful. -
Diabetes, fetal growth and stillbirth
Diabetes, fetal growth and stillbirthWomen suffering from type 1 or type 2 diabetes are more likely to suffer from stillbirths. We want to help people with diabetes to have healthy pregnancies.